Strides Pharma Science in its consolidated financial results for the quarter Q3FY25 ended December 31, 2024 reported revenues of Rs. 1,153.7 crore with a growth 14.6% YoY in Q3FY25. The PAT stood at ...

Strides Pharma Science Ltd (BOM:532531) reports a robust quarter with 13.3% revenue growth and significant debt reduction, while navigating challenges in regulated markets.

Revenue increased 15% YoY at ₹1,153.7 crore from ₹1,005.8 crore in Q3 FY24, marking a consistent business growth.

Arun Kumar, Founder and Executive Chairperson of the Company, has served in various positions on the Board of Strides since its inception. His current appointment as Executive Director is expiring on ...

Strides Pharma Science is well on track to achieve the FY25 outlook of $275 million-$290 million, post-demerger.

Bangalore: Strides Pharma Science Limited has announced that the Company has received an ESG score of 76/100 and CSA score of ...

Strides Pharma debuts with a stellar ESG rating of 76/100 in the S&P Global’s Corporate Sustainability Assessment: Our Bureau, Bengaluru Wednesday, January 22, 2025, 13:40 Hrs [ ...

Ajith Kumar's much-anticipated film 'Vidaamuyarchi' will be released on February 6, 2025. The newly released trailer, directed by Magizh Thirumeni and featuring a gripping action thriller with ...

Ajith Kumar is one of the most celebrated actors in Tamil cinema, and the actor's career began in 1990 with the film 'En Veedu En Kanavar'. Over the years, he has cemented his place as one of the ...

Calculate here Kumar brings three decades of experience in banking in different capacities. As executive director of Punjab National Bank since November 2022, he was responsible for corporate banking, ...